We are live on
!
Find out more
Verition Fund Management Portfolio holdings
AUM
$15.4B
1-Year Est. Return
30.69%
This Fund
S&P 500
This Quarter
Est. Return
+4.5%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$7.5B
AUM Growth
+$268M
(+3.7%)
Cap. Flow
-$1.1B
Cap. Flow
% of AUM
-14.7%
Top 10 Holdings %
Top 10 Hldgs %
9.03%
Holding
2,747
New
633
Increased
574
Reduced
601
Closed
591
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Horizon
FHN
|
+$45M |
| 2 |
American Electric Power
AEP
|
+$44.9M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$42.1M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$39.8M |
| 5 |
RenaissanceRe
RNR
|
+$37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$55.4M |
| 2 |
NextEra Energy
NEE
|
+$47.3M |
| 3 |
Targa Resources
TRGP
|
+$22.4M |
| 4 |
Toll Brothers
TOL
|
+$22.3M |
| 5 |
Broadcom
AVGO
|
+$21.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.37% |
| 2 | Industrials | 9.47% |
| 3 | Technology | 7.75% |
| 4 | Healthcare | 7.65% |
| 5 | Utilities | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HLGN
1851
DELISTED
Heliogen, Inc.
HLGN
| $98K | ﹤0.01% |
+11,429
| New | +$105K |
|
1852
Sundial Growers
SNDL
$312M
| $98K | ﹤0.01% |
+71,500
| New | +$109K |
|
1853
Xeris Biopharma Holdings
XERS
$1.45B
| $97K | ﹤0.01% |
+37,008
| New | +$94.2K |
|
|
KZR
1854
DELISTED
Kezar Life Sciences
KZR
| $96.9K | ﹤0.01% |
3,956
-2,951
| -43% | -$76.8K |
|
|
MCHB
1855
Mechanics Bancorp
MCHB
$3.65B
| $94.3K | ﹤0.01% |
+15,922
| New | +$150K |
|
|
AIM
1856
AIM ImmunoTech
AIM
$6.65M
| $93.8K | ﹤0.01% |
1,401
-40
| -3% | -$1.93K |
|
|
HOUS
1857
DELISTED
Anywhere Real Estate
HOUS
| $93.7K | ﹤0.01% |
+14,022
| New | +$84.1K |
|
1858
Outlook Therapeutics
OTLK
$187M
| $93.3K | ﹤0.01% |
+2,680
| New | +$73.1K |
|
1859
Innoviz Technologies
INVZ
$84.1M
| $92.3K | ﹤0.01% |
32,509
+2,000
| +7% | +$5.52K |
|
1860
Advantage Solutions
ADV
$575M
| $92.1K | ﹤0.01% |
1,575
+536
| +52% | +$22.9K |
|
|
LAZR
1861
DELISTED
Luminar Technologies
LAZR
| $91.2K | ﹤0.01% |
+884
| New | +$83.5K |
|
1862
Cipher Digital
CIFR
$7.24B
| $89.8K | ﹤0.01% |
31,414
-51,428
| -62% | -$127K |
|
|
ONL
1863
Orion Office REIT
ONL
$151M
| $89.4K | ﹤0.01% |
+13,524
| New | +$84.3K |
|
1864
AXT Inc
AXTI
$2.42B
| $87.4K | ﹤0.01% |
25,393
+14,568
| +135% | +$49.1K |
|
1865
Oscar Health
OSCR
$9.22B
| $86.2K | ﹤0.01% |
+10,700
| New | +$78.9K |
|
1866
Absci
ABSI
$1.17B
| $86.2K | ﹤0.01% |
56,724
+20,898
| +58% | +$33.6K |
|
1867
Verrica Pharmaceuticals
VRCA
$89M
| $86.1K | ﹤0.01% |
1,493
+367
| +33% | +$22.3K |
|
1868
Relmada Therapeutics
RLMD
$540M
| $85.4K | ﹤0.01% |
+34,700
| New | +$95.9K |
|
1869
PLAYSTUDIOS Inc
MYPS
$76.2M
| $83.6K | ﹤0.01% |
+17,030
| New | +$74.6K |
|
1870
Rayonier Advanced Materials
RYAM
$562M
| $83.5K | ﹤0.01% |
+19,505
| New | +$92.3K |
|
1871
ClearPoint Neuro
CLPT
$424M
| $81.8K | ﹤0.01% |
+11,302
| New | +$96.1K |
|
1872
Nordic American Tanker
NAT
$1.36B
| $81.5K | ﹤0.01% |
22,200
-67,500
| -75% | -$244K |
|
|
BRY
1873
DELISTED
Berry Corp
BRY
| $80.3K | ﹤0.01% |
+11,670
| New | +$84.1K |
|
|
WW
1874
DELISTED
WW International
WW
| $77.5K | ﹤0.01% |
11,528
-21,415
| -65% | -$152K |
|
1875
Cue Biopharma
CUE
$118M
| $76.7K | ﹤0.01% |
+700
| New | +$82.3K |
|
Similar funds
RFC
NMO
EH
OAC
UM
EF
Verition Fund Management's Q2 2023 Portfolio in Review
As of Q2 2023, Verition Fund Management held 2,747 positions worth $7.5B, up 3.7% from $7.23B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Verition Fund Management withdrew a net $1.1B in Q2 2023, closing 591 positions and reducing 601 holdings. Its most notable exit was PotlatchDeltic, an estimated $18.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Industrials and Technology.
Against the trend, Verition Fund Management opened a new position in First Horizon worth $37.8M.
- Verition Fund Management's largest Q2 2023 buy was First Horizon: 3,355,153 shares worth $37.8M.
- Verition Fund Management added most to American Electric Power in Q2 2023, an estimated $44.9M increase.
- Verition Fund Management's biggest Q2 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $55.4M.
- Verition Fund Management fully exited PotlatchDeltic in Q2 2023, selling an estimated $18.8M.
- Verition Fund Management's ten largest holdings make up 9% of its $7.5B portfolio in Q2 2023.
- Verition Fund Management opened 633 new positions and closed 591 in Q2 2023.
- Verition Fund Management's portfolio value rose 3.7% quarter-over-quarter to $7.5B.
Based on Verition Fund Management's 13F filing for Q2 2023, filed 14 Aug 2023.